Elixir Pharmaceuticals Private Limited

Elixir Pharmaceuticals Private Limited - pharma in Gurgaon, Haryana, India. FY 2026 financials & compliance.
CIN U85100HR2020PTC087947 Incorporated 29 July 2020 ROC Delhi HQ Gurgaon, Haryana, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹9.07 Lakh
▼ 41% YoY
Net loss · FY 2025
₹577
Net margin -0.1%
EBITDA · FY 2025
₹12,218
EBITDA margin 1.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Elixir Pharmaceuticals Private Limited

Data last updated:

Elixir Pharmaceuticals Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 July 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100HR2020PTC087947. Its GSTIN is 09AAGCE0088F1ZO (Uttar Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prashant Kumar Agarwal and Vishal Agarwal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Adani Oyster Grande Flat No D – 102 Opp. Delhi Public School Sector – 102, Gurgaon, Haryana, India – 122001.

As per the financials filed for FY 2025, the company reported a revenue of ₹9.07 Lakh, a decline of 41% compared to the previous year. For the same year it recorded a net loss of ₹577 (net margin -0.1%) and EBITDA of ₹12,218 (EBITDA margin 1.3%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years.

Elixir Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0005125).

Company Details of Elixir Pharmaceuticals Private Limited
CIN U85100HR2020PTC087947
Registration Number 087947
Incorporation Date 29 July 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-HR-05-0005125
Key People
Prashant Kumar Agarwal Director Vishal Agarwal Director

Recognitions & Rankings of Elixir Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-HR-05-0005125
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    C/O Adani Oyster Grande Flat No D – 102 Opp. Delhi Public School Sector – 102, Gurgaon, Haryana, India – 122001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Elixir Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Elixir Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Elixir Pharmaceuticals Private Limited in one report.

Financials from FY 2021 Directors & ownership Charges & compliance

Business Activity of Elixir Pharmaceuticals Private Limited

The main business activity of Elixir Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcyclesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Elixir Pharmaceuticals Private Limited FY 2025 filings available

Elixir Pharmaceuticals Private Limited reported revenue of ₹9.07 Lakh (down 41% YoY) for FY 2025.

Revenue · FY 2025
₹9.07 Lakh ▼ 41%
Net loss · FY 2025
₹577 margin -0.1%
EBITDA · FY 2025
₹12,218 margin 1.3%

Compounded Annual Growth Rate (CAGR) of Elixir Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▼ 41%
3 years · compounded
▼ 11%
EBITDA CAGR growth
1 year
▼ 61%
3 years · compounded
▼ 28%

Revenue has declined at a compounded annual rate (CAGR) of 11% over three years, including a 41% fall in the latest year. EBITDA fell 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Elixir Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹12,218••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹577••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Elixir Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.3%••••••••••••••••
Net Profit Margin-0.1%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Elixir Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2021

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Elixir Pharmaceuticals Private Limited

Elixir Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Prashant Kumar Agarwal
Also directs: Zodiac Surgical & Medicine Private Limited, Luxmisairam Foods Private Limited
Director29 Jul 20206 Years 2 MonthsCurrent
Vishal Agarwal
Also directs: Zodiac Surgical & Medicine Private Limited, Luxmisairam Foods Private Limited
Director29 Jul 20206 Years 2 MonthsCurrent
View all directors

Peer Comparison of Elixir Pharmaceuticals Private Limited

Elixir Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Healthon Pharmaceuticals Private Limited₹9.11 Lakh (FY 2016)••••••••9.0%••••Kochi, Kerala, India
Atbu Harita Pharmaceuticals Private Limited₹9.11 Lakh (FY 2024)••••••••-9.0%••••Vyara, Gujarat, India
Livway Pharmaceuticals Private Limited₹9.11 Lakh (FY 2025)••••••••33.0%••••Delhi, India
Adils Pharmaceuticals Private Limited₹9.11 Lakh (FY 2024)••••••••-15.0%••••Lucknow, Uttar Pradesh, India
Hari Cure Pharmaceuticals Private Limited₹9.07 Lakh (FY 2025)••••••••-30.0%••••Patna, Bihar, India
Elixir Pharmaceuticals Private Limited this company₹9.07 Lakh (FY 2025)••••••••-41.0%••••Gurgaon, Haryana, India
Freefind Pharmaceuticals Private Limited₹9.07 Lakh (FY 2024)••••••••••••Aligarh, Uttar Pradesh, India
Triozone Pharmaceuticals Private Limited₹9.05 Lakh (FY 2019)••••••••7.0%••••New Delhi, Delhi, India
Bhartiya Pharmaceuticals India Private Limited₹9.05 Lakh (FY 2016)••••••••779.0%••••Indore, Madhya Pradesh, India
Soxil Drugs and Pharmaceuticals Pvt Ltd₹9.03 Lakh (FY 2025)••••••••0.0%••••Ajmer, Rajasthan, India
Lifesource Pharmaceuticals Private Limited₹9.03 Lakh (FY 2025)••••••••15.0%••••Mumbai Dt 6 2, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Elixir Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Elixir Pharmaceuticals Private Limited

Elixir Pharmaceuticals Private Limited is audited by ANANT AGARWAL & CO. for the financial year 2024.

NameStatusAppointment DateCessation Date
ANANT AGARWAL & CO.LockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Elixir Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Elixir Pharmaceuticals Private Limited

Elixir Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Elixir Pharmaceuticals Private Limited

Elixir Pharmaceuticals Private Limited has a workforce of 0 employees as of Mar 03, 2025.

Active EPFO establishments
1
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Elixir Pharmaceuticals Private Limited

Elixir Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Prashant Kumar Agarwal was appointed as Director on 29 Jul 2020.

AGM
Elixir Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Elixir Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Prashant Kumar Agarwal was appointed as Director.
Appointed
Vishal Agarwal was appointed as Director.
Incorporation
29 Jul 2020
Elixir Pharmaceuticals Private Limited was registered on 29 Jul 2020 with Roc Delhi & aged 6 years 2 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Elixir Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Elixir Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Elixir Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Elixir Pharmaceuticals Private Limited

Elixir Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAGCE0088F1ZOUttar PradeshActive27 Oct 2020
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Elixir Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Elixir Pharmaceuticals Private Limited

Elixir Pharmaceuticals is an active private limited company based in Gurgaon, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 July 2020 (6+ years old) and is registered under CIN U85100HR2020PTC087947.

Elixir Pharmaceuticals reported revenue of ₹9.07 Lakh for FY 2025 (down 41% YoY).

Elixir Pharmaceuticals has 2 current directors:

Elixir Pharmaceuticals reported a net loss of ₹577 (net margin -0.1%) and EBITDA of ₹12,218 (EBITDA margin 1.3%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Elixir Pharmaceuticals is -11% over three years. In the latest year (FY 2025) revenue fell 41%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Elixir Pharmaceuticals is 09AAGCE0088F1ZO, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Elixir Pharmaceuticals is U85100HR2020PTC087947. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Elixir Pharmaceuticals was incorporated on 29 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Elixir Pharmaceuticals by revenue are Healthon Pharmaceuticals Private Limited, Atbu Harita Pharmaceuticals Private Limited, Livway Pharmaceuticals Private Limited, Adils Pharmaceuticals Private Limited, Hari Cure Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Prashant Kumar Agarwal was appointed as Director on 29 Jul 2020. Vishal Agarwal was appointed as Director on 29 Jul 2020.

Yes, Elixir Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-05-0005125).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available